Clinical Trial: Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With